FlexPlan project: considering flexibility to support long-term grid planning
FlexPlan project highlighted at Innogrid 2020 The H2020 FlexPlan project aims at developing and testing a new grid planning tool, considering investments in flexibility, storage, grid reinforcements/expansion for transmission and distribution grids. Environmental and...
UCB and N-SIDE increase their strategic collaboration
N-SIDE is very pleased to announce that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. With this new agreement, UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services to...
Accelerate time to market with clinical supply optimization – Read our white paper!
Wastage in clinical trials is accepted as the norm. Large buffers are added to protect the trial, to ensure that there is enough drug product when and where the patients need it, and to ensure that the trial runs to completion. But adding estimated buffers at...
N-SIDE Quarantine Travel Challenge
Due to the lockdown situation, we have seen our holiday plans cancelled and we are now longing for adventures in exotic places or dreaming of a weekend getaway, but unfortunately, we are all stuck at home. Well, in these uncertain times, it’s important that we keep...
N-SIDE officially becomes a Certified B Corporation™!
On March 23, N-SIDE was officially awarded the B Corp Certification! We are now one of the 3275 B Corporations worldwide Using Business as a Force for Good™. What is a B Corp™? B Lab™, the nonprofit behind B Corp Certifications defines B Corporations™ as follows:...
Current research directions against COVID-19
The fight against COVID-19 is still at its early stages. There are currently several research directions undertaken by pharmaceutical companies. Our Life Sciences Director, Sébastien Coppe, was interviewed by the Belgian media to highlight the key trends of ongoing...